Assessing the impact of the CMS price transparency rule on patients with prostate cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

“It’s the prices, stupid,” Uwe E. Reinhardt and authors famously wrote in their 2003 article describing the cause of high health care spending in the United States.1 Since then, multiple large analyses have confirmed that the prices of labor and goods, including pharmaceuticals and administrative costs, more so than differences in utilization, are the primary drivers of high health care spending.2,3

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Ankit Agarwal, MD, MBA
Resident physician, Department of Radiation Oncology, University of North Carolina at Chapel Hill
Trevor J. Royce, MD, MS, MPH
Assistant professor, Department of Radiation Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Table of Contents

YOU MAY BE INTERESTED IN

The University of California, San Francisco and global oncology communities mourn the death of Felix Y. Feng, MD, a radiation oncologist and a leading figure in genitourinary cancer research. A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng died from cancer on Dec.10, 2024. He was 48.
The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.
Ankit Agarwal, MD, MBA
Resident physician, Department of Radiation Oncology, University of North Carolina at Chapel Hill
Trevor J. Royce, MD, MS, MPH
Assistant professor, Department of Radiation Oncology, UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login